Online citations, reference lists, and bibliographies.

Lipids In Oral Controlled Release Drug Delivery

B. Boyd, T. Nguyen, A. Müllertz
Published 2011 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Lipids can perform many useful functions that modify or otherwise enhance drug absorption or disposition. They may influence release/absorption-controlling processes such as gastro retention and muco-adhesion. They can facilitate lymphatic transport of lipophilic drugs, and make them less susceptible to “first pass effects” by avoiding or reducing the hepatic portal route. Understanding lipid digestion and structure formation in vivo is key to exploiting possibilities for their use in controlling absorption or disposition. In particular, liquid crystalline structures are being increasingly investigated for their roles in the aforementioned processes. Such phenomena and possibilities are discussed in this chapter.
This paper references
10.1016/J.IJPHARM.2006.05.056
In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
J. Hamdani (2006)
10.1021/CM0522681
New Role for Urea as a Surfactant Headgroup Promoting Self-Assembly in Water
C. Fong (2006)
10.1113/jphysiol.1968.sp008411
A relation between the chain length of fatty acids and the slowing of gastric emptying.
J. N. Hunt (1968)
10.1246/CL.2006.830
Hexagonal Liquid-crystalline Nanoparticles in Aqueous Mixtures of Glyceryl Monooleyl Ether and Pluronic F127
J. Barauskas (2006)
10.1152/ajpregu.1979.236.5.R254
Calories and gastric emptying: a regulatory capacity with implications for feeding.
P. McHugh (1979)
10.1016/S0142-9612(96)00087-7
An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99/water gels.
P. Geraghty (1997)
10.1016/j.jconrel.2011.03.033
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
T. Nguyen (2011)
10.1016/J.EJPS.2006.04.016
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
C. Pouton (2006)
10.1136/gut.29.8.1035
Measurement of gastrointestinal pH profiles in normal ambulant human subjects.
D. F. Evans (1988)
10.1152/AJPGI.00189.2007
Development and physiological regulation of intestinal lipid absorption. I. Development of intestinal lipid absorption: cellular events in chylomicron assembly and secretion.
D. Black (2007)
10.1016/S0169-409X(96)00488-7
Structure and function of gastro-intestinal lipases
Jonathan Kenneth Embleton (1997)
10.1023/A:1015827908309
Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women
J. Dressman (1990)
10.1002/ANIE.200301683
Cubic liquid-crystalline nanoparticles.
D. Yang (2004)
10.1002/jps.2600620918
Biopharmaceutics of drugs administered in lipid-containing dosage forms. I. GI absorption of griseofulvin from an oil-in-water emulsion in the rat.
P. Carrigan (1973)
10.1016/J.ADDR.2007.10.010
Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
C. Pouton (2008)
10.1194/JLR.E400004-JLR200
A comprehensive classification system for lipids11 The evaluation of this manuscript was handled by the former Editor-in-Chief Trudy Forte. Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.E400004-JLR200
E. Fahy (2005)
10.1016/S0169-409X(01)00147-8
An examination of the factors affecting intestinal lymphatic transport of dietary lipids.
B. K. Nordskog (2001)
10.1016/0959-440X(95)80042-5
Kinetics of lipid phase changes.
M. Caffrey (1995)
10.1016/0168-3659(94)90255-0
The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time☆
F. Pozzi (1994)
10.1208/pt0802030
Floating granules of ranitidine hydrochloride-gelucire 43/01: Formulation optimization using factorial design
D. Patel (2008)
10.1093/AJCN/70.6.1096
Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract.
M. Armand (1999)
10.1016/0014-5793(95)00660-2
From entangled membranes to eclectic morphologies: cubic membranes as subcellular space organizers
T. Landh (1995)
10.1016/S0021-9150(00)00456-1
Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.
E. Ros (2000)
10.1016/S0378-5173(03)00262-X
Characterisation of drug release from cubosomes using the pressure ultrafiltration method.
B. Boyd (2003)
10.1016/j.ijpharm.2008.08.022
Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
K. W. Lee (2009)
10.1208/pt050343
Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation
S. Shimpi (2008)
10.1021/LA061706V
Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
Yao-Da Dong (2006)
10.1016/0169-409X(91)90046-F
Transport of lipophilic molecules by the intestinal lymphatic system
W. Charman (1991)
10.3109/10611869909085515
Lectins for gastrointestinal targeting--15 years on.
J. Woodley (2000)
10.1016/0022-2836(88)90607-9
Cubic phases of lipid-containing systems. Structure analysis and biological implications.
P. Mariani (1988)
10.1016/j.jconrel.2008.10.002
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Houli Li (2009)
A CUBIC-PHASE DELIVERY SYSTEM COMPOSED OF GLYCERYL MONOOLEATE AND WATER FOR SUSTAINED RELEASE OF WATER-SOLUBLE DRUGS
D. M. Wyatt (1992)
10.1016/J.JCONREL.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
10.1007/BF01490251
Cubic phases in surfactant and surfactant-like lipid systems
K. Fontell (1990)
10.1081/DDC-100100341
Hot-Melt Coating Technology. I. Influence of Compritol® 888 Ato and Granule Size on Theophylline Release
A. Faham (2000)
10.1016/J.IJPHARM.2003.12.025
Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices.
Kiran Kumar M (2004)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1039/B609510K
Ordered 2-D and 3-D nanostructured amphiphile self-assembly materials stable in excess solvent.
Thomas Kaasgaard (2006)
10.1021/LA010161W
Novel Process for Producing Cubic Liquid Crystalline Nanoparticles (Cubosomes)
Patrick T. Spicer and (2001)
Studies on Formulation and optimization of Gastro Retentive multi- Particulates of Glibenclamide and Metformin hydrochloride for the treatment of Type II Diabetes mellitus using Gelucire: A Review.
P. Upadhyay (2010)
10.1002/j.1552-4604.1993.tb04673.x
Effect of Food and a Monoglyceride Emulsion Formulation on Danazol Bioavailability
W. Charman (1993)
10.1016/0378-5173(79)90046-2
Biopharmaceutical studies of lipid-containing oral dosage forms: Relationship between drug absorption rate and digestibility of vehicles
Yamahira Yoshiya (1979)
10.1016/0378-5173(92)90374-B
Systemic bioavailability of penclomedine (NSC-338720) from oil-in-water emulsions administered intraduodenally to rats
R. A. Myers (1992)
10.1016/J.JCONREL.2005.05.015
Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids.
J. Clogston (2005)
10.1021/bi00460a011
Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings.
J. Staggers (1990)
10.1021/LA030410B
Aqueous phase behavior of a 1-O-phytanyl-beta-D-xyloside/water system. Glycolipid-based bicontinuous cubic phases of crystallographic space groups Pn3m and Ia3d.
M. Hato (2004)
10.1021/JP071324D
Diversifying the solid state and lyotropic phase behavior of nonionic urea-based surfactants.
C. Fong (2007)
10.3109/08982100903443065
Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability
J. Varshosaz (2010)
10.1016/S0169-409X(01)00108-9
Cubic phase gels as drug delivery systems.
J. Shah (2001)
10.1016/j.ijpharm.2009.10.049
Understanding polymer-lipid solid dispersions--the properties of incorporated lipids govern the crystallisation behaviour of PEG.
Johan Unga (2010)
10.1023/A:1018888927852
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Shicheng Yang (2004)
10.1146/annurev.ph.45.030183.003251
Lipid digestion and absorption.
M. Carey (1983)
10.1002/jps.2600650304
Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in rats.
D. Bloedow (1976)
10.1016/j.jconrel.2009.01.009
Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.
W. Fong (2009)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1007/b11629
Phase behavior of phytanyl-chained akylglycoside/water systems
M. Hato (2004)
10.1002/JPS.10329
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
Greg A Kossena (2003)
10.1016/S0378-5173(00)00485-3
The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment.
S. Khoo (2000)
10.1007/s00280-008-0849-9
Enhanced absorption and tissue distribution of paclitaxel following oral administration of DHP 107, a novel mucoadhesive lipid dosage form
B. Shin (2008)
10.1016/S0169-409X(01)00182-X
In vitro assessment of oral lipid based formulations.
C. J. Porter (2001)
10.1016/S0009-3084(00)00182-1
Phase behavior of a monoacylglycerol: (myverol 18-99K)/water system.
J. Clogston (2000)
10.1016/S0378-5173(98)00180-X
Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase
Chin-Ming Chang (1998)
10.1016/S0731-7085(00)00528-8
Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis.
L. Sek (2001)
10.1002/JPS.21246
Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs.
Jean F Cuiné (2008)
10.1021/la0350812
Phase behavior of the phytantriol/water system
J. Barauskas (2003)
10.1021/bi00460a012
Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings.
O. Hernell (1990)
10.1016/S0959-440X(97)80075-9
Biological significance of lipid polymorphism: the cubic phases.
V. Luzzati (1997)
10.1007/s11095-007-9363-8
Low Dose Lipid Formulations: Effects on Gastric Emptying and Biliary Secretion
Greg A Kossena (2007)
10.1113/jphysiol.1975.sp010841
The volume and energy content of meals as determinants of gastric emptying.
J. N. Hunt (1975)
10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V
Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats.
S. Caliph (2000)
10.1007/BF02915334
A classification of biologic lipids based upon their interaction in aqueous systems
D. Small (1968)
10.1016/J.IJPHARM.2006.05.052
Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization.
J. Hamdani (2006)
10.1166/JNN.2007.809
Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.
L. Priano (2007)
10.1002/jps.2600640513
Bioavailability of micronized griseofulvin from corn oil-in-water emulsion, aqueous suspension, and commercial tablet dosage forms in humans.
T. R. Bates (1975)
10.1172/JCI113820
Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein.
W. Stremmel (1988)
10.1016/S0169-409X(96)00489-9
Influence of lipolysis on drug absorption from the gastro-intestinal tract
Karen J. MacGregor (1997)
10.1016/0304-4157(89)90020-8
Cubic phases and isotropic structures formed by membrane lipids — possible biological relevance
G. Lindblom (1989)
10.1016/S0378-5173(02)00298-3
Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases.
B. Siekmann (2002)
10.1208/s12249-009-9292-4
Glyceryl Monooleate/Poloxamer 407 Cubic Nanoparticles as Oral Drug Delivery Systems: I. In Vitro Evaluation and Enhanced Oral Bioavailability of the Poorly Water-Soluble Drug Simvastatin
J. Lai (2009)
10.1016/S1773-2247(07)50051-1
Development of a multi-unit floating drug delivery system by hot melt coating technique with drug-lipid dispersion
K. Chansanroj (2007)
10.1016/S0016-5085(75)80228-9
Control of gastric emptying by osmolality of duodenal contents in man.
J. Meeroff (1975)
10.1016/0378-5173(94)00347-8
Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix
K. Westesen (1995)
10.1016/J.JCONREL.2007.10.025
The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
A. Dahan (2008)
10.1002/jps.2600760404
Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs.
T. Tokumura (1987)
10.1002/jps.21832
An investigation into the mechanism of dissolution rate enhancement of poorly water-soluble drugs from spray chilled gelucire 50/13 microspheres.
Sheng Qi (2010)
10.1039/F29767201525
Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers
J. Israelachvili (1976)
10.1016/J.IJPHARM.2006.03.006
Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
F. Siepmann (2006)
10.1113/jphysiol.1962.sp006957
The regulation of gastric emptying of meals containing citric acid and salts of citric acid.
J. N. Hunt (1962)
10.1016/S0928-0987(00)00167-6
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
C. Pouton (2000)
10.1016/S0378-5173(02)00316-2
Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.
F. Damian (2002)
10.1016/J.JCONREL.2004.06.013
A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs.
Greg A Kossena (2004)
10.1021/JS980403L
Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.
A. T. Serajuddin (1999)
10.1071/CH05173
Submicron Dispersions of Hexosomes Based on Novel Glycerate Surfactants
C. Fong (2005)
10.1093/JN/128.12.2403
Gastric digestion modifies absorption of butterfat into lymph chylomicrons in rats.
H. Lai (1998)
10.1016/0927-7757(94)02743-9
The science and applications of emulsions — an overview☆
J. Israelachvili (1994)
10.1021/LA7029714
Self-assembled geometric liquid-crystalline nanoparticles imaged in three dimensions: hexosomes are not necessarily flat hexagonal prisms.
Ben J Boyd (2007)
10.1080/03639040500271837
Preparation and Evaluation of Floating Risedronate Sodium–Gelucire® 43/01 Formulations
B. Chauhan (2005)
10.1007/s11095-010-0199-2
The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein Profiles
Natalie L Trevaskis (2010)
10.1002/jps.21547
Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
Ping Li (2009)
10.1016/S1359-0294(00)00020-0
Surfactant self-assembly objects as novel drug delivery vehicles
C. Drummond (1999)
10.1152/ajpcell.1996.271.1.C172
Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolism.
L. Hool (1996)
10.1007/s00125-001-0751-z
Self-assembled “nanocubicle” as a carrier for peroral insulin delivery
H. Chung (2001)
10.1016/J.IJPHARM.2007.03.020
A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
B. Boyd (2007)
10.1007/BF02233016
Control of gastric emptying
J. N. Hunt (1968)
10.1152/ajpgi.1994.267.6.G1142
Small intestinal capsaicin-sensitive afferents mediate feedback inhibition of gastric emptying in rats.
T. Zittel (1994)
10.1016/S0169-409X(96)00494-2
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
A. Humberstone (1997)
10.1016/S0076-6879(09)64006-4
Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
E. Souto (2009)
10.1152/ajpgi.1996.271.1.G172
Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum.
M. Armand (1996)
Visualization by freeze fracture, in vitro and in vivo, of the products of fat digestion.
M. Rigler (1986)
10.1016/0378-5173(95)04431-0
Matrix pellets based on the combination of waxes, starches and maltodextrins
F. Zhou (1995)
Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.
T. Lindmark (1995)
10.1016/0016-5085(93)90908-U
Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans.
F. Carrière (1993)
10.1021/JS970300N
Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
D. Hauss (1998)
10.14227/DT170310P34
Formulation and Characterization of Floating Gelucire Matrices of Metoprolol Succinate
Praneeth Kumar Siripuram (2010)
10.1113/jphysiol.1960.sp006577
The osmotic effects of some simple molecules and ions on gastric emptying.
J. N. Hunt (1960)
10.2174/157341308783591816
Solid Lipid Nanoparticles (SLNs) as a Rising Tool in Drug Delivery Science: One Step Up in Nanotechnology
S. Vyas (2008)
10.1126/science.1070967-a
Self-Assembly of Phase-Segregated Liquid Crystal Structures
T. Kato (2002)
Studies on fat digestion, absorption, and transport in the suckling rat. I. Fatty acid composition and concentrations of major lipid components.
G. J. Fernando-Warnakulasuriya (1981)
10.1152/ajpgi.1981.241.5.G403
Search for resistances controlling canine gastric emptying of liquid meals.
J. Miller (1981)
10.1016/j.physbeh.2004.07.032
Apolipoprotein A-IV, food intake, and obesity
P. Tso (2004)
10.1016/S0928-0987(97)10004-5
Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate.
L. S. Nielsen (1998)
10.1081/DDC-100102144
Extrusion-spheronization manufacture of Gelucire matrix beads.
C. Montoussé (1999)
10.1211/JPP.62.07.0006
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
Tri-Hung Nguyen (2010)
Mucoadhesive liposomes : physicochemical properties and release behavior of water-soluble drugs from chitosan-coated liposomes
H. Yamamoto (2000)
10.1016/J.IJPHARM.2005.11.033
Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems.
B. Boyd (2006)
10.1016/0005-2760(85)90221-8
Secretion of human gastric lipase from dispersed gastric glands.
S. Denigris (1985)
10.1016/0378-5173(90)90381-D
Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model
M. Y. Levy (1990)
10.1016/J.EJPB.2007.01.017
The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
A. Dahan (2007)
10.1016/0955-2863(94)90083-3
Hydrolysis of emulsions with different triglycerides and droplet sizes by gastric lipase in vitro. Effect on pancreatic lipase activity
P. Borel (1994)
10.1016/0378-5173(93)90015-8
A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure
B. Magenheim (1993)
10.1016/S0378-5173(00)00361-6
Studies on the cyclosporin A loaded stearic acid nanoparticles.
Q. Zhang (2000)
10.1021/LA0013805
Bending frustration of lipid-water mesophases based on cubic minimal surfaces.
U. Schwarz (2001)
10.1021/LA062344U
Liquid crystalline phases and their dispersions in aqueous mixtures of glycerol monooleate and glyceryl monooleyl ether.
G. Popescu (2007)
10.1124/jpet.109.154542
Lymphatic Transport of Methylnortestosterone Undecanoate (MU) and the Bioavailability of Methylnortestosterone Are Highly Sensitive to the Mass of Coadministered Lipid after Oral Administration of MU
K. White (2009)
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives
Melike Üner (2007)
Hot melt coating technology: influence of Compritol 888 Ato and granule size on chloroquine release.
A. Faham (2000)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar